Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
October 09, 2017 | Global Health Council blog
Microbicides: Innovative solutions to help women stay HIV-free
No one product will end the HIV/AIDS epidemic. Women urgently need new prevention options, particularly discreet methods they can use without partner involvement. More »
October 05, 2017 | HIV Plus Magazine
Innovative Vaginal Ring Is a New HIV Prevention Method for Women
The International Partnership for Microbicides (IPM) received an award from the United States Agency for International Development (USAID) to support the ongoing research of an HIV-prevention device... More »
October 02, 2017 | The BMJ
Zeda Rosenberg: determined to empower women to prevent HIV infection
Today Rosenberg heads the International Partnership for Microbicides (IPM), a non-profit organisation that is developing a microbicide eluting vaginal ring that has been shown to prevent HIV... More »
September 25, 2017 | MD Magazine
IPM Received Up to $25 Million To Accelerate Vaginal Ring Designed to Reduce HIV-1
The International Partnership for Microbicides (IPM) received up to $25 million throughout 5 years from the United States Agency for International Development to accelerate the potential rollout of... More »
September 18, 2017 | MD Magazine
HIV PrEP Treatment Works Well for At-risk Teenage Boys
In conjunction with the published study, the NIH is funding PrEP therapy studies for African females aged 16-21. The subjects will use a vaginal ring for 6 months, oral PrEP for another 6 months,... More »